美國射頻消融術設備市場規模、佔有率和趨勢分析報告：按產品、應用和細分市場分類（2026-2033 年）

美國射頻消融術設備疼痛管理市場概況。

2025年美國用於疼痛管理的射頻消融術設備市場規模估計為4.777億美元，預計2033年將達到10.291億美元。

從 2026 年到 2033 年，市場預計將以 10.1% 的複合年成長率成長。這一成長是由關節炎和神經病變等慢性疼痛疾病的患病率上升、對微創和非鴉片類治療方法的需求增加以及人們持續減少長期使用鴉片類藥物所驅動的。

此外，RFA 技術的進步、臨床結果的改善以及患者和醫療保健專業人員意識的提高，進一步推動了美國市場的擴張。

美國慢性疼痛盛行率的不斷上升是射頻消融術（RFA）疼痛管理設備市場成長的根本促進因素。慢性疼痛通常定義為持續三個月或更長時間的疼痛，是人們尋求醫療保健服務的最常見原因之一。根據美國疾病管制與預防中心（CDC）預測，到2023年，約24.3%的美國成年人（約6,000萬人）將患有慢性疼痛，其中8.5%的人患有嚴重慢性疼痛，嚴重影響其日常生活。不斷擴大的患者群體直接推動了對先進、微創疼痛管理解決方案（如RFA）的需求，與傳統治療方法相比，RFA能夠提供更有針對性且更持久的疼痛緩解。

近年來慢性疼痛盛行率的持續上升是推動市場成長的關鍵因素之一。這與人口老化、久坐的生活方式、肥胖以及肌肉骨骼和神經病變疾病發病率的增加密切相關。隨著越來越多的患者從急性疼痛發展為慢性疼痛，臨床需求正轉向射頻消融術（RFA）等介入性治療。 RFA 可在神經節阻斷疼痛訊號，進而減少患者對藥物的長期依賴。此外，由於慢性疼痛與功能障礙和生活品質下降密切相關，因此有效管理已成為臨床工作的首要任務。超過 2,100 萬美國人飽受嚴重慢性疼痛的困擾，這常常影響他們的工作效率和日常生活。為了應對這種情況，醫療專業人員正在積極推廣治療方法。 RFA 設備透過提供精準的神經消融來滿足這一需求，尤其適用於骨關節炎、脊椎疼痛和癌症相關疼痛等疾病，因此在醫院和門診診所中得到了迅速普及。

目錄

第1章：美國射頻消融術鎮痛設備市場：調查方法與範圍

第2章：美國製造的疼痛管理的射頻消融術設備：執行摘要

• 市場概覽
• 細分市場概覽
  • 按產品查看
  • 按最終用途分類的展望
• 競爭格局概述

第3章：美國用於疼痛管理的射頻消融術設備：影響因素、趨勢和範圍

• 市場譜系展望
• 採用率和成長前景圖
• 產業價值鏈分析
  • 還款框架
• 市場動態
• 美國用於疼痛管理的射頻消融術設備分析工具
  • 產業分析：波特五力分析
  • PESTEL 分析

第4章：美國射頻消融術鎮痛設備：產品規模估算與趨勢分析

• 產品特定波動分析、市場佔有率、2025 年及 2033 年
• 市場規模、預測與趨勢分析：按產品分類，2021-2033 年
• RFA電極/探針
  • RFA電極和探針市場估算和預測（2021-2033年）
  • 拋棄式的
  • 可重複使用的
• 射頻消融套管（或針頭）
  • 射頻消融套管（或針頭）市場估算與預測（2021-2033 年）
• RFA生成器
  • 射頻產生器市場估算與預測（2021-2033）
• 其他
  • 其他市場估算與預測（2021年至2033年）

第5章：美國用於疼痛管理的射頻消融術設備：按最終用途分類的市場規模估算和趨勢分析

• 按最終用途分類的市場佔有率，2025 年和 2033 年
• 市場規模、預測和趨勢分析：按最終用途分類，2021-2033 年
• 醫院
  • 醫院市場估計與預測，2021-2033年
• 門診設施
  • 門診設施市場估算與預測（2021-2033 年）
• 其他
  • 其他市場估計與預測，2021-2033年

第6章 競爭情勢

• 參與企業概況
• 公司市場分析
• 公司分類
• 策略規劃
• 公司簡介列表
  • Stryker Corporation
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Avanos Medical, Inc
  • Epimed International, Inc.
  • Medline Inc.
  • Elevaris Medical Devices

U.S. Radiofrequency Ablation Devices For Pain Management Market Summary

The U.S. radiofrequency ablation devices for pain management market size was estimated at USD 477.7 million in 2025 and is projected to reach USD 1,029.1 million by 2033, growing at a CAGR of 10.1% from 2026 to 2033. This growth is driven by the rising prevalence of chronic pain conditions such as arthritis and neuropathic disorders, increasing demand for minimally invasive and non-opioid treatment options, and the ongoing shift away from long-term opioid use.

Additionally, advancements in RFA technology, improved clinical outcomes, and growing awareness among both patients and healthcare providers are further supporting market expansion across the U.S.

The rising prevalence of chronic pain conditions in the U.S. is a fundamental driver for the growth of the radiofrequency ablation (RFA) devices for pain management market. Chronic pain, typically defined as pain lasting more than three months, has become one of the most common reasons for healthcare utilization. According to the Centers for Disease Control and Prevention, nearly 24.3% of U.S. adults, approximately 60 million people, experienced chronic pain in 2023, with 8.5% suffering from high-impact chronic pain that significantly limits daily activities. This expanding patient pool directly increases the demand for advanced, minimally invasive pain management solutions such as RFA, which offer targeted and longer-lasting relief compared to conventional therapies.

A key aspect contributing to market growth is the consistent upward trend in chronic pain prevalence over recent years which is linked to aging populations, sedentary lifestyles, obesity, and higher incidence of musculoskeletal and neuropathic disorders. As more patients progress from acute to chronic pain stages, the clinical need shifts toward interventional procedures like RFA, which can disrupt pain signals at the nerve level and reduce long-term dependency on pharmacological treatments. Moreover, chronic pain is strongly associated with functional limitations and reduced quality of life, making effective management a clinical priority. High-impact chronic pain affects over 21 million Americans, often impairing work productivity and daily functioning. This has encouraged healthcare providers to adopt procedures that provide sustained relief with fewer systemic side effects. RFA devices meet this demand by offering precise nerve ablation, particularly in conditions such as osteoarthritis, spinal pain, and cancer-related pain, thereby accelerating their adoption across hospitals and outpatient settings.

U.S. Radiofrequency Ablation Devices For Pain Management Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. radiofrequency ablation devices for pain management market report based on product and end-use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• RFA Electrodes/ Probes
  • Disposable
  • Reusable
• RFA Cannula (or Needles)
• RFA Generators
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Outpatient Facilities
• Others

Table of Contents

Chapter 1. U.S. Radiofrequency Ablation Devices for Pain Management Market: Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. U.S. Radiofrequency Ablation Devices for Pain Management: Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
  • 2.2.1. Product outlook
  • 2.2.2. End use outlook
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Radiofrequency Ablation Devices for Pain Management: Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
  • 3.4.2. Market Restraint Analysis
• 3.5. U.S. Radiofrequency Ablation Devices for Pain Management Analysis Tools
  • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.5.1.1. Supplier Power
    • 3.5.1.2. Buyer Power
    • 3.5.1.3. Substitution Threat
    • 3.5.1.4. Threat of New Entrants
    • 3.5.1.5. Competitive Rivalry
  • 3.5.2. PESTLE Analysis

Chapter 4. U.S. Radiofrequency Ablation Devices for Pain Management: Product Estimates & Trend Analysis

• 4.1. Product Movement Analysis & Market Share, 2025 & 2033
• 4.2. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.3. RFA Electrodes/ Probes
  • 4.3.1. RFA Electrodes/ Probes Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.3.2. Disposable
    • 4.3.2.1. Disposable Market Estimates & Forecasts 2021 to 2033 (USD Million)
  • 4.3.3. Reusable
    • 4.3.3.1. Reusable Market Estimates & Forecasts 2021 to 2033 (USD Million)
• 4.4. RFA Cannula (or Needles)
  • 4.4.1. RFA Cannula (or Needles) Market Estimates & Forecasts 2021 to 2033 (USD Million)
• 4.5. RFA Generators
  • 4.5.1. RFA Generators Market Estimates & Forecasts 2021 to 2033 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Estimates & Forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Radiofrequency Ablation Devices for Pain Management: End Use Estimates & Trend Analysis

• 5.1. End Use Market Share, 2025 & 2033
• 5.2. End Use Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.5. Outpatient Facilities
  • 5.5.1. Outpatient Facilities Market Estimates & Forecasts, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Participant Overview
• 6.2. Company Market Position Analysis
• 6.3. Company Categorization
• 6.4. Strategy Mapping
• 6.5. Company Profiles/Listing
  • 6.5.1. Stryker Corporation
    • 6.5.1.1. Company Overview
    • 6.5.1.2. Financial Performance
    • 6.5.1.3. Product Benchmarking
    • 6.5.1.4. Strategic Initiatives
  • 6.5.2. Abbott Laboratories
    • 6.5.2.1. Company Overview
    • 6.5.2.2. Financial Performance
    • 6.5.2.3. Product Benchmarking
    • 6.5.2.4. Strategic Initiatives
  • 6.5.3. Medtronic plc
    • 6.5.3.1. Company Overview
    • 6.5.3.2. Financial Performance
    • 6.5.3.3. Product Benchmarking
    • 6.5.3.4. Strategic Initiatives
  • 6.5.4. Boston Scientific Corporation
    • 6.5.4.1. Company Overview
    • 6.5.4.2. Financial Performance
    • 6.5.4.3. Product Benchmarking
    • 6.5.4.4. Strategic Initiatives
  • 6.5.5. Avanos Medical, Inc
    • 6.5.5.1. Company Overview
    • 6.5.5.2. Financial Performance
    • 6.5.5.3. Product Benchmarking
    • 6.5.5.4. Strategic Initiatives
  • 6.5.6. Epimed International, Inc.
    • 6.5.6.1. Company Overview
    • 6.5.6.2. Financial Performance
    • 6.5.6.3. Product Benchmarking
    • 6.5.6.4. Strategic Initiatives
  • 6.5.7. Medline Inc.
    • 6.5.7.1. Company Overview
    • 6.5.7.2. Financial Performance
    • 6.5.7.3. Product Benchmarking
    • 6.5.7.4. Strategic Initiatives
  • 6.5.8. Elevaris Medical Devices
    • 6.5.8.1. Company Overview
    • 6.5.8.2. Financial Performance
    • 6.5.8.3. Product Benchmarking
    • 6.5.8.4. Strategic Initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 U.S. radiofrequency ablation devices for pain management market, By product, 2021 - 2033 (USD Million)
• Table 4 U.S. radiofrequency ablation devices for pain management market, By end use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Competitive landscape
• Fig. 10 U.S. radiofrequency ablation devices for pain management market dynamics
• Fig. 11 U.S. radiofrequency ablation devices for pain management market: Porter's five forces analysis
• Fig. 12 U.S. radiofrequency ablation devices for pain management market: PESTLE analysis
• Fig. 13 U.S. radiofrequency ablation devices for pain management market: product movement analysis
• Fig. 14 U.S. radiofrequency ablation devices for pain management market: product outlook and key takeaways
• Fig. 15 RFA Electrodes/ Probes market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 16 Disposable market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 17 Reusable market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 18 RFA Cannula (or Needles) market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 19 RFA Generators Market Estimates and Forecast, 2021 - 2033 (USD Million)
• Fig. 20 Others market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 21 U.S. radiofrequency ablation devices for pain management market: End use movement analysis
• Fig. 22 U.S. radiofrequency ablation devices for pain management market: End use outlook and key takeaways
• Fig. 23 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 24 Outpatient facilities market estimates and forecast, 2021 - 2033 (USD Million)
• Fig. 25 Others market estimates and forecast, 2021 - 2033 (USD Million)